6A rvin AM. V aricella vaccine: genesis, efficacy, and attenuation [J]. V iro logy, 2001,284(2) :153.
7A rgaw T, Cohen J I, Klutch M , et al. N ucleo tide sequences that distinguish Oka vaccine from parental Oka and other varicella 2 zo ster virus iso lates[J ]. Infect Dis, 2000, 181(3) :1153.
8Brisson M, Edmunds W, Gay N, et al. Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunization programs. Vaccine, 2000,18: 2775-2778.
9Chaves SS, Gargiullo P, Zhang JX, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med, 2007, 356: 1121-1129.
10Davis MM. Successes and remaining challenges after 10 years of varicella vaccination in the USA. Expert Rev Vaccines, 2006, 5 (2) :295-302.
